Clinical trials for prostate cancer
50 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 2
Prostate cancer
#NCT05489211
Metastatic Castration-resistant
Systemic Treatment-Naive
Antibody Drug Conjugates (ADC)
Centre Hospitalier Universitaire de Bordeaux (Bordeaux), Centre Léon Bérard (Lyon), Hôpital Foch (Suresnes)
AstraZeneca
Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
#NCT05118789
SCLC (Small Cell Lung Cancer)
Mesothelium
Locally Advanced
Metastatic
Metastatic Castration-resistant
ROS-1
Other mutation
Systemic Treatment-Naive
Centre Léon Bérard (Lyon), Gustave Roussy (Villejuif), Centre Hospitalier Universitaire - Site Hôtel Dieu (Nantes), Centre Hospitalier Universitaire de Toulouse (Toulouse)
Nuvalent Inc.
Phase 2
Prostate cancer
#NCT03438552
Adenocarcinoma
Biochemical recurrence
Radiotherapy
Systemic Treatment-Naive
Immunotherapy
Chemotherapy
Car-T
Bispecific T-cell engager antibodies
Antibody Drug Conjugates (ADC)
Centre François Baclesse (Caen ), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Centre Jean Perrin (Clermont Ferrand ), Institut du cancer de Montpellier (Montpellier), Centre Oscar Lambret (Lille) (and 6 more...)
UNICANCER
Phase 2
Prostate cancer
#NCT02628067
Immunotherapy
Systemic Treatment-Naive
Immunotherapy
Gustave Roussy (Villejuif)
Merck Sharp & Dohme LLC
Phase 2
Prostate cancer
#NCT04585750
Metastatic Castration-resistant
Systemic Treatment-Naive
IUCT Oncopôle (Toulouse), Centre Léon Bérard (Lyon), ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg), Gustave Roussy (Villejuif), Institut Bergonié (Bordeaux) (and 2 more...)
PMV Pharmaceuticals, Inc
Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
#NCT05751798
MSI/dMMR
PDL1 Positive (1% <= X < 25%)
PDL1 Positive (25% <= X < 50%)
PDL1 Positive (>= 50%)
Systemic Treatment-Naive
Immunotherapy
Systemic Treatment-Naive
Immunotherapy
Centre Léon Bérard (Lyon)
OSE Immunotherapeutics
Phase 2
Breast cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
#NCT05384626
Locally Advanced
Metastatic
Metastatic Castration-resistant
Other mutation
BRAF
MET
HER2
RET
NTRK-1/2/3
KRAS G12C
KRAS non G12C
BRCA 1/2
AKT
PIK3CA
PALB2
ESR
FGFR
PTEN
MSI/dMMR
ATM
CDK12
HOXB13
CHEK 1/2
NRAS
Systemic Treatment-Naive
Gustave Roussy (Villejuif), IUCT Oncopôle (Toulouse), Centre Léon Bérard (Lyon), Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain)
Nuvalent Inc.
Phase 2
Prostate cancer
#NCT03845751
Localized
Systemic Treatment-Naive
Institut Mutualiste Montsouris (Paris)
Institut Mutualiste Montsouris
Phase 2
Prostate cancer
#NCT05346848
Localized
Systemic Treatment-Naive
Chemotherapy
Hormone therapy
Radiotherapy
Internal Vectorised Radiotherapy (IVR)
Surgery
Institut Bergonié (Bordeaux)
Institut Bergonié
Phase 2
Prostate cancer
#NCT04536805
Biochemical recurrence
Radiotherapy
Surgery
Hormone therapy
Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest), Centre Oscar Lambret (Lille), Centre Léon Bérard (Lyon), Centre Hospitalier Universitaire Laennec (Saint-Herblain), Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ) (and 1 more...)
Institut de Cancérologie de l'Ouest